查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609979

镰状细胞贫血检测和筛检市场规模、份额、趋势分析报告：按技术、按年龄组、按行业类型、按地区、细分市场预测，2025-2030 年

Sickle Cell Anemia Testing And Screening Market Size, Share & Trends Analysis Report By Technology (Hemoglobin Electrophoresis, Point-of-Care Tests), By Age Group, By Sector Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

镰状细胞贫血检测和筛检市场成长和趋势

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球镰状贫血检测和筛检市场规模预计将达到 8.295 亿美元，2025 年至 2030 年复合年增长率为 12.1%。血红素 S (HbS) 是镰状细胞疾病的病原体，镰状细胞疾病是目前全球最受欢迎的疾病或遗传异常，特别是在新兴经济体。

镰状细胞血红素的变异体包括 HbS、HbA 和 HbC。已经开发了各种测试来清楚地区分上述所有三种血红蛋白变体。深度学习框架的开发旨在透过智慧型手机显微镜从患者血液抹片样本中自动筛检镰状细胞性贫血，这可能会在不久的将来为市场开闢新的途径。

市场适度整合，主要市场参与企业努力透过联盟和收购维持市场竞争，并扩大在新生儿检测市场的业务。同时，新兴企业正在探索就地检验的潜力，以赢得市场竞争。

血红蛋白电泳和高效液相层析法在政府主导的新生儿筛检计画和评估研究中的使用正在迅速增加，导致市场渗透率的提高。因此，它引起了渴望改进现有产品线的公司的注意，进一步增加了产品的消费。

镰状细胞性贫血检测和筛检市场报告亮点

  • 按年龄组别划分，世界各地已采用多种新生儿筛检计划，以有效控制这种疾病的负担。这些程序利用各种测试，包括等电聚焦/醋酸纤维素电泳、高效液相层析(HPLC) 和溶解度测试。
  • 从技术上来看，POC横向流动化验是筛检计画中首选的检测方法，构成了传统的检测工具。
  • 按部门类型划分，政府实验室长期以来一直是镰状细胞检测的最大采用者。
  • 政府实验室正在积极参与透过鼓励基于镰状的镰状细胞检测来促进这些检测的采用。
  • 对联邦和基金会资金的需求不断增加，以解决血红蛋白病和囊肿纤维化等疾病的治疗和诊断方面的医疗保健差异，预计将引起监管机构的关注。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章镰状细胞贫血症检测和筛检市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章镰状细胞性贫血检测与筛检市场：依技术、商业分析

  • 2024 年和 2030 年按技术分類的市场占有率
  • 技术板块细分仪表板
  • 2018-2030 年按技术分類的市场规模、预测与趋势分析
  • 血红素电泳
  • 高效液相层析（HPLC）
  • 就地检验
  • 其他的

第五章镰状细胞性贫血检测与筛检市场：依年龄层、业务分析

  • 2024 年及 2030 年按年龄层分類的市场占有率
  • 年龄层细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按行业类型）
  • 新生儿筛检（12个月以下）
  • 成人筛检（25-60岁）
  • 其他（1-25岁及60岁以上）

第六章镰状细胞性贫血检测与筛检市场：依产业类型、业务分析

  • 2024 年和 2030 年按行业类型分類的市场占有率
  • 按部门类型细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按行业类型）
  • 政府实验室
  • 私人实验室
  • 企业实验室
  • PPP（官民合作关係）

第七章镰状细胞性贫血检测和筛检市场：按技术、按地区、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章镰状细胞性贫血检测和筛检市场：按年龄层、地区、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第 9 章镰状细胞贫血症检测和筛检市场：按行业类型、按地区、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
Product Code: GVR-4-68038-761-2

Sickle Cell Anemia Testing And Screening Market Growth & Trends:

The global sickle cell anemia testing and screening market size is expected to reach USD 829.5 million by 2030, expanding at a CAGR of 12.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Hemoglobin S (HbS) is the causative factor for sickle cell disease and is currently the most prevailing disease or genetic abnormality across the globe, specifically across developing economies.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

The market is moderately consolidated, wherein the key industry participants are striving to sustain market competition via partnerships, acquisitions, and expanding their business across newborn testing market space. Whereas, emerging companies are exploring potential of point-of-care tests to gain a competitive edge in the market.

A steep increase in the uptake of Hb electrophoresis and HPLC across government-initiated newborn screening programs and assessment studies have resulted in robust market penetration. This has, in turn, caught the attention of companies who are keen on modifying their existing product line, further amplifying consumption of the same.

Sickle Cell Anemia Testing And Screening Market Report Highlights:

  • By age group, several newborn screening programs have been employed across the globe to effectively manage the burden of this disease. These programs make use of different tests such as isoelectric focusing/ cellulose acetate electrophoresis, high-performance liquid chromatography (HPLC), and solubility tests
  • Based on technology, POC lateral flow assays are the most preferred testing methodologies in screening programs, forming the conventional means of testing
  • On the basis of sector type, government laboratories have witnessed maximum employment of sickle cell tests over the years
  • Government laboratories have actively participated in promoting the adoption of these tests by encouraging population-based sickle cell testing
  • Rise in the demand for federal and foundation funding to address healthcare disparities treatments and diagnosis of diseases, such as hemoglobinopathies and cystic fibrosis, is expected to drive the attention of the regulatory agencies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Age Group
    • 1.2.3. Sector Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sickle Cell Anemia Testing & Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Sickle Cell Anemia Testing & Screening Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Hemoglobin Electrophoresis
    • 4.4.1. Hemoglobin Electrophoresis Market, 2018 - 2030 (USD Million)
    • 4.4.2. Isoelectric Focusing
      • 4.4.2.1. Isoelectric Focusing Market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. High-Performance Liquid Chromatography (HPLC)
    • 4.5.1. High-Performance Liquid Chromatography (HPLC) Market, 2018 - 2030 (USD Million)
  • 4.6. Point-of-Care Tests
    • 4.6.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)
    • 4.6.2. Lateral Flow Immunoassay
      • 4.6.2.1. Lateral Flow Immunoassay Market, 2018 - 2030 (USD Million)
    • 4.6.3. Paper-Based Rapid Diagnostics
      • 4.6.3.1. Paper-Based Rapid Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.7. Other Tests
    • 4.7.1. Other Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Sickle Cell Anemia Testing & Screening Market: Age Group Business Analysis

  • 5.1. Age Group Market Share, 2024 & 2030
  • 5.2. Age Group Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
  • 5.4. Newborn Screening (12 months and below)
    • 5.4.1. Newborn Screening (12 months and below) Market, 2018 - 2030 (USD Million)
  • 5.5. Adult Screening (25 to 60 years)
    • 5.5.1. Adult Screening (25 to 60 years) Market, 2018 - 2030 (USD Million)
  • 5.6. Other Age Groups (1 to 25 & above 60 years)
    • 5.6.1. Other Age Groups (1 to 25 & above 60 years) Market, 2018 - 2030 (USD Million)

Chapter 6. Sickle Cell Anemia Testing & Screening Market: Sector Type Business Analysis

  • 6.1. Sector Type Market Share, 2024 & 2030
  • 6.2. Sector Type Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Sector Type, 2018 to 2030 (USD Million)
  • 6.4. Government Labs
    • 6.4.1. Government Labs Market, 2018 - 2030 (USD Million)
  • 6.5. Private Labs
    • 6.5.1. Private Labs Market, 2018 - 2030 (USD Million)
  • 6.6. Corporate Labs
    • 6.6.1. Corporate Labs Market, 2018 - 2030 (USD Million)
  • 6.7. PPP (Public-Private-Partnerships)
    • 6.7.1. PPP (Public-Private-Partnerships) Market, 2018 - 2030 (USD Million)

Chapter 7. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Technology

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Age Group

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Sickle Cell Anemia Testing & Screening Market: Regional Estimates & Trend Analysis by Sector Type

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Norway Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Denmark Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Sweden
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Sweden Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Japan Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. China Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. South Korea Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Australia
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. Australia Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Sickle Cell Anemia Testing & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 4. Global sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 5. Global sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 6. Global sickle cell anemia testing & screening market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 9. North America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 10. North America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 11. U.S. sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 12. U.S. sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 13. U.S. sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 14. Canada sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 15. Canada sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 16. Canada sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 17. Mexico sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 18. Mexico sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 19. Mexico sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 20. Europe sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 22. Europe sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 23. Europe sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 24. UK sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 25. UK sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 26. UK sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 27. Germany sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Germany sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 29. Germany sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 30. France sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 31. France sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 32. France sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 33. Italy sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 34. Italy sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 35. Italy sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 36. Spain sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 37. Spain sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 38. Spain sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 39. Norway sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 40. Norway sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 41. Norway sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 42. Denmark sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Denmark sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 44. Denmark sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 45. Sweden sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 46. Sweden sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 47. Sweden sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 52. Japan sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 53. Japan sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 54. Japan sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 55. China sickle cell anemia testing & screening market, by technology, 2018-2030 (USD Million)
  • Table 56. China sickle cell anemia testing & screening market, by age group, 2018-2030 (USD Million)
  • Table 57. China sickle cell anemia testing & screening market, by sector type, 2018-2030 (USD Million)
  • Table 58. India sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 59. India sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 60. India sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 61. Australia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 62. Australia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 63. Australia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 64. South Korea sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 65. South Korea sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 66. South Korea sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 67. Thailand sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 68. Thailand sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 69. Thailand sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 70. Latin America sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 71. Latin America sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 72. Latin America sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million
  • Table 73. Latin America sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million
  • Table 74. Brazil sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 75. Brazil sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 76. Brazil sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 77. Argentina sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 78. Argentina sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 79. Argentina sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa sickle cell anemia testing & screening market, by country, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 83. Middle East & Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 84. South Africa sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 85. South Africa sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 86. South Africa sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 90. UAE sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 91. UAE sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 92. UAE sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)
  • Table 93. Kuwait sickle cell anemia testing & screening market, by technology, 2018 - 2030 (USD Million)
  • Table 94. Kuwait sickle cell anemia testing & screening market, by age group, 2018 - 2030 (USD Million)
  • Table 95. Kuwait sickle cell anemia testing & screening market, by sector type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Sickle cell anemia testing & screening market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology outlook (USD Million)
  • Fig. 10 Transportation mode outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Sickle cell anemia testing & screening market dynamics
  • Fig. 13 Sickle cell anemia testing & screening market: Porter's five forces analysis
  • Fig. 14 Sickle cell anemia testing & screening market: PESTLE analysis
  • Fig. 15 Sickle cell anemia testing & screening market: Technology segment dashboard
  • Fig. 16 Sickle cell anemia testing & screening market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Hemoglobin electrophoresis market, 2018 - 2030 (USD Million)
  • Fig. 18 High-performance liquid chromatography (HPLC) market, 2018 - 2030 (USD Million)
  • Fig. 19 Point-of-care tests market, 2018 - 2030 (USD Million)
  • Fig. 20 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 21 Sickle cell anemia testing & screening market: Age Group segment dashboard
  • Fig. 22 Sickle cell anemia testing & screening market: Age Group market share analysis, 2024 & 2030
  • Fig. 23 Newborn screening (12 months and below) market, 2018 - 2030 (USD Million)
  • Fig. 24 Adult screening (25 to 60 years) market, 2018 - 2030 (USD Million)
  • Fig. 25 Other age groups (1 to 25 & above 60 years) market, 2018 - 2030 (USD Million)
  • Fig. 26 Sickle cell anemia testing & screening market: Sector type segment dashboard
  • Fig. 27 Sickle cell anemia testing & screening market: Sector type market share analysis, 2024 & 2030
  • Fig. 28 Government labs market, 2018 - 2030 (USD Million)
  • Fig. 29 Private labs market, 2018 - 2030 (USD Million)
  • Fig. 30 Corporate labs market, 2018 - 2030 (USD Million)
  • Fig. 31 PPP (public private partnerships) market, 2018 - 2030 (USD Million)
  • Fig. 32 Sickle cell anemia testing & screening market revenue, by region
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait sickle cell anemia testing & screening market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework